Serenium

The submission contains major red flags that severely impact credibility. While the stated problem of sleep apnea diagnosis is genuine, the project claims a 2014 launch but remains 'pending FDA approval' twelve years later. Furthermore, stating 'most people have used my product' for an unapproved medical device is entirely false, and citing a $2.5M market cap as 'monthly revenue' demonstrates fundamental misunderstandings. These factors, alongside vague audience targets ('everyone'), firmly place this project in the negative calibration tier.